Inventor · disambiguated record
Stefan Knackmuss
Also filed as: KNACKMUSS STEFAN
15 granted patents·2 pending applications·141 citations·filing 2002–2021
92Inventor score
Files withAFFIMED GMBH6AMPHIVENA THERAPEUTICS INC4AFFIMED THERAPEUTICS AG3HOFFMANN KARIN1LINHARD CLAUDIA1
Top patents by PatentIndex Score
17 records- 0192US9212225B1Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·17 cites·14 claims
- 0292US9035026B2Anti-CD16 binding moleculesHOFFMANN KARIN·Filed 2006·Granted May 19, 2015·54 cites·21 claims
- 0390US9803029B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·11 cites·18 claims
- 0489US9701750B2Anti-CD16 binding moleculesAFFIMED GMBH·Filed 2015·Granted Jul 11, 2017·11 cites·16 claims
- 0588US10626190B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 0685US10066015B2CD3 binding domainsAFFIMED GMBH·Filed 2015·Granted Sep 4, 2018·10 cites·11 claims
- 0780US7812136B2Antibody of human origin specifically binding to activated state of platelet integrin receptor GPIIb/IIIaAFFIMED THERAPEUTICS AG·Filed 2002·Granted Oct 12, 2010·18 cites·7 claims
- 0874US10273309B2Antibody binding sites specific for EGFRvIIIAFFIMED GMBH·Filed 2016·Granted Apr 30, 2019·2 cites·21 claims
- 0971US7507797B2Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereofAFFIMED THERAPEUTICS AG·Filed 2004·Granted Mar 24, 2009·11 cites·14 claims
- 1069US7901677B1Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer typesAFFIMED THERAPEUTICS AG·Filed 2006·Granted Mar 8, 2011·1 cites·13 claims
- 1165US12264198B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2021·Granted Apr 1, 2025·0 cites·11 claims
- 1265US2021024654A1Bispecific CD33 and CD3 Binding ProteinsAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1361US9365647B2Compounds for use in the treatment of Alzheimer's diseaseWEISS STEFAN FRANZ THOMAS·Filed 2012·Granted Jun 14, 2016·1 cites·4 claims
- 1461US8455627B2Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIaLINHARD CLAUDIA·Filed 2010·Granted Jun 4, 2013·2 cites·4 claims
- 1560US11180558B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2019·Granted Nov 23, 2021·0 cites·11 claims
- 1646US2016361413A1Compounds for use in the treatment of alzheimer's diseaseUNIV JOHANNESBURG WITWATERSRAND·Filed 2016·Application pending·0 cites
- 1741US11167029B2Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapyAFFIMED GMBH·Filed 2017·Granted Nov 9, 2021·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Stefan Knackmuss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →